Delivery Order SPE2DB24D9250-SPE2DB25FJVKH
Award Date
11/22/24
Potential Completion Date
12/16/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of Mirena 52 mg systems, a contraceptive device, to the Defense Logistics Agency's (DLA) Medical Supply Chain division. The $8,347.58 firm fixed-price delivery order has an ultimate completion date of October 22, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $8,880.00, is for the delivery of the Mirena 52 mg contraceptive system. DMS Pharmaceutical Group has a significant $499,999,999 indefinite delivery contract (IDC) with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $7,104.00 under the Defense Logistics Agency's (DLA) SPE2DB program. The contract is for the supply of Mirena 52 mg systems, a contraceptive product, to support the recurring medical supply needs of military health facilities. The contract is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order worth $1,776.00 under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, valued at up to $499,999,999, covers a wide range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities worldwide. The delivery order is for the Mirena 52 mg contraceptive system, a specialized...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of Mirena 52 mg Systems over a period ending on October 8, 2024. The $17,760.00 firm fixed-price delivery order was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued...
This firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $3,552.00 contract is to provide the Mirena 52 mg systems, a contraceptive device, with an ultimate completion date of August 20, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $17,760.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which runs through October 2, 2024, is for the delivery of Mirena 52 mg systems, a branded contraceptive device. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $7,811.55 firm fixed-price delivery order is for the supply of MIRENA 52 MG SYSTEMS, a contraceptive device, with a period of performance through June 4, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Mirena 52 mg systems. The contract has a ceiling value of $15,623.10 and a period of performance through February 4, 2025. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the provision of Mirena 52 mg systems. The $1,184 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under the agency's Medical Supply Chain program. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that supplies a wide range of medications, including branded and generic prescription drugs, over-the-counter products, biologics, and medical...